Fairvalue-Calculator Fairvalue-Calculator
EN DE

Shandong Bailong Chuangyuan Bio-Tech Co (605016) Fair Value & Analysis

Consumer Defensive · CN · Market cap 10.6B CNY

Price¥24.81
Fair Value¥18.43
Upside-25.7%
Quality95/100
Evidence: High Range ¥13.82 – ¥23.43

Analysis

Shandong Bailong Chuangyuan Bio-Tech Co (605016) currently trades at ¥24.81, while our model-based Fair Value estimate is ¥18.43 — implying the stock looks roughly 25.7% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltitol, organic maltodextrin, allulose psicose, isomalt, and isomaltulose, as well as allulose powder and maltitol syrups. The company sells its products to manufacturers, traders, and retail customers of food, beverages, dairy products, health products, pharmaceuticals, animal nutrition, and feed sectors. Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. was founded in 2005 and is based in Yucheng, China.

Open the full interactive analysis →

Similar stocks

Nestlé S.A (NSRGF) -28% Foshan Haitian Flavouring and Food Company (603288) -30% Nestlé India Limited (NESTLEIND) -80% Grupo Bimbo, S.A. (BIMBOA) +46% Uni-President Enterprises Corp (1216) -17% Britannia Industries Limited (BRITANNIA) -73%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.